BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36950259)

  • 1. Drinking alcohol to cope with hyperactive ADHD? Self-reports vs. continuous performance test in patients with ADHD and/or alcohol use disorder.
    Luderer M; Seidt J; Gerhardt S; Hoffmann S; Vollstädt-Klein S; Reif A; Sobanski E
    Front Psychiatry; 2023; 14():1112843. PubMed ID: 36950259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective assessment of attention-deficit/hyperactivity disorder in older adults compared with controls using the QbTest.
    Bijlenga D; Ulberstad F; Thorell LB; Christiansen H; Hirsch O; Kooij JJS
    Int J Geriatr Psychiatry; 2019 Oct; 34(10):1526-1533. PubMed ID: 31243809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.
    Stevanovic D; Wentz E; Nasic S; Knez R
    BMC Psychiatry; 2022 Apr; 22(1):282. PubMed ID: 35448977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised controlled trial.
    Hall CL; Walker GM; Valentine AZ; Guo B; Kaylor-Hughes C; James M; Daley D; Sayal K; Hollis C
    BMJ Open; 2014 Dec; 4(12):e006838. PubMed ID: 25448628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Quantified Behavioral Test-A Confirmatory Test in the Diagnostic Process of Adult ADHD?
    Brunkhorst-Kanaan N; Verdenhalven M; Kittel-Schneider S; Vainieri I; Reif A; Grimm O
    Front Psychiatry; 2020; 11():216. PubMed ID: 32265761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol investigating the clinical utility of an objective measure of attention, impulsivity and activity (QbTest) for optimising medication management in children and young people with ADHD 'QbTest Utility for Optimising Treatment in ADHD' (QUOTA): a feasibility randomised controlled trial.
    Hall CL; James M; Brown S; Martin JL; Brown N; Selby K; Clarke J; Vijayan H; Guo B; Sayal K; Hollis C; Groom MJ
    BMJ Open; 2018 Feb; 8(2):e021104. PubMed ID: 29453304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach.
    Hall CL; Valentine AZ; Walker GM; Ball HM; Cogger H; Daley D; Groom MJ; Sayal K; Hollis C
    BMC Psychiatry; 2017 Feb; 17(1):66. PubMed ID: 28183284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult attention-deficit/hyperactivity disorder among alcohol use disorder inpatients is associated with food addiction and binge eating, but not BMI.
    El Ayoubi H; Barrault S; Gateau A; Cortese S; Frammery J; Mollat E; Bonnet-Brilhault F; Grall-Bronnec M; Ballon N; Brunault P
    Appetite; 2022 Jan; 168():105665. PubMed ID: 34455024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary evidence for altered motion tracking-based hyperactivity in ADHD siblings.
    Reh V; Schmidt M; Rief W; Christiansen H
    Behav Brain Funct; 2014 Mar; 10():7. PubMed ID: 24624931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of attention-deficit/hyperactivity disorder symptom severity with severity of alcohol-related problems in a sample of inpatients with alcohol use disorder.
    Bozkurt M; Evren C; Umut G; Evren B
    Neuropsychiatr Dis Treat; 2016; 12():1661-7. PubMed ID: 27462159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale.
    Kessler RC; Green JG; Adler LA; Barkley RA; Chatterji S; Faraone SV; Finkelman M; Greenhill LL; Gruber MJ; Jewell M; Russo LJ; Sampson NA; Van Brunt DL
    Arch Gen Psychiatry; 2010 Nov; 67(11):1168-78. PubMed ID: 21041618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsive Personality Traits Mediate the Relationship Between Attention-Deficit/Hyperactivity Disorder Symptoms and Psychiatric Comorbidity among Patients with Severe Alcohol Use Disorder.
    Brandt L; Levin FR; Kraigher D
    J Dual Diagn; 2021; 17(3):193-206. PubMed ID: 34313557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol use disorders and ADHD.
    Luderer M; Ramos Quiroga JA; Faraone SV; Zhang James Y; Reif A
    Neurosci Biobehav Rev; 2021 Sep; 128():648-660. PubMed ID: 34265320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADHD and the QbTest: Diagnostic Validity of QbTest.
    Hult N; Kadesjö J; Kadesjö B; Gillberg C; Billstedt E
    J Atten Disord; 2018 Sep; 22(11):1074-1080. PubMed ID: 26224575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder.
    Bijlenga D; Jasperse M; Gehlhaar SK; Sandra Kooij JJ
    Eur Psychiatry; 2015 Jan; 30(1):179-85. PubMed ID: 25172155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence of parent report and laboratory measures of inattention and hyperactivity in children with heavy prenatal alcohol exposure.
    Glass L; Graham DM; Deweese BN; Jones KL; Riley EP; Mattson SN
    Neurotoxicol Teratol; 2014; 42():43-50. PubMed ID: 24512965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique and Transdiagnostic Dimensions of Reward Functioning in Attention-Deficit/Hyperactivity Disorder and Alcohol Use Disorder Symptoms.
    Oddo LE; Acuff SF; Arenson MB; Oshri A; Chronis-Tuscano A; MacKillop J; Murphy JG
    Alcohol Alcohol; 2022 Jul; 57(4):452-459. PubMed ID: 34632479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
    Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
    Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.